Place of polytherapy in the early treatment of epilepsy

CNS Drugs

Volumn 16, Issue 3, 2002, Pages 155-163

  Deckers, Charles L P ^a,b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b STICHTING EPILEPSIE INSTELLINGEN NEDERLAND SEIN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; TIAGABINE; VALPROIC ACID; VIGABATRIN;

CLINICAL TRIAL; DRUG CHOICE; DRUG EFFICACY; DRUG MECHANISM; EPILEPSY; FOCAL EPILEPSY; HUMAN; PRIORITY JOURNAL; RASH; REVIEW; SEIZURE; TONIC CLONIC SEIZURE; TREATMENT FAILURE;

EID: 0036218024     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-200216030-00002     Document Type: Review

References (39)

1. Antiepileptic drug monotherapy versus polytherapy: A historical perspective
2. Monotherapy or polytherapy for epilepsy?
3. Monotherapy versus polytherapy
4. One drug for epilepsy
5. Reduction in polypharmacy for epilepsy
6. Reduction of polypharmacy in epileptic patients
7. Reduction of two-drug therapy in intractable epilepsy
8. Anticonvulsant drugs and cognitive functions
9. Relating pharmacology to clinical practice: The pharmacologic basis of rational polypharmacy
10. Rationalized polytherapy for epilepsy
11. Is there a mechanistic basis for rational polypharmacy?
12. Monotherapy and polypharmacy
13. Selection of antiepileptic drug polytherapy based on mechanisms of action: The evidence reviewed
14. Reappraisal of polytherapy in epilepsy: A critical review of drug load and adverse effects
15. Drug load in clinical trials: A neglected factor
16. Monotherapy or polytherapy for epilepsy revisited: A quantitative assessment
17. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults
18. A multicentre comparative trial of sodium valproate and carbamazepine in adult onset epilepsy
19. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy
20. Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy
21. A randomized open multicentre comparative trial of lamotrigine and carbamazepine as monotherapy in patients with newly diagnosed or recurrent epilepsy
22. Carbamazepine in comparative trials: Pharmacokinetic characteristics too often forgotten
23. Carbamazepine vs. diphenylhydantoin vs. their combination in adult epilepsy
24. Alternative single anticonvulsant drug therapy for refractory epilepsy
25. Success with alternate antiepileptic drug selection
26. Vigabatrin vs. carbamazepine monotherapy in newly diagnosed focal epilepsy: A randomized response conditional cross-over study
27. Newly diagnosed epileptic seizure disorder in adults. A prospective follow-up study on 100 patients
28. Carbamazepine versus valproate versus combined therapy for refractory partial complex seizures with secondary generalization
29. The choice of antiepileptic drugs in focal epilepsy
30. Epilepsy after the first drug fails: Substitution or add-on?
31. The efficacy of carbamazepine combinations in epilepsy
32. Lamotrigine substitution study: Evidence for synergism with valproate?
33. Open study evaluating lamotrigine efficacy and safety in add-on treatment and consecutive monotherapy in patients with carbamazepine- or valproate-resistant epilepsy
34. Adjunctive tiagabine compared with phenytoin and carbamazepine in the multicenter, double-blind trial of complex partial seizures
35. Double-blind substitution of vigabatrin and valproate in carbamazepine-resistant partial epilepsy
36. Monotherapy versus polytherapy for epilepsy: A multi-center double-blind randomized study
37. Monotherapy versus polytherapy in epilepsy: A reappraisal
38. Survey of 260 epileptic patients treated with oxcarbazepine (Trileptal) on a named-patient basis
39. Long-term therapy with antiepileptic drugs